238 related articles for article (PubMed ID: 4388462)
21. Clinical usefulness of beta-adrenergic blocking agents.
Conn RD
Postgrad Med; 1974 Feb; 55(2):131-6. PubMed ID: 4855696
[No Abstract] [Full Text] [Related]
22. Clinical pharmacology of beta-receptor-blocking drugs.
Dollery CT; Paterson JW; Conolly ME
Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4393717
[No Abstract] [Full Text] [Related]
23. Clinical and hemodynamic appraisal of beta adrenergic blocking drugs.
Epstein SE; Braunwald E
Ann N Y Acad Sci; 1967 Feb; 139(3):952-67. PubMed ID: 5342364
[No Abstract] [Full Text] [Related]
24. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)].
Guardigli R
Minerva Cardioangiol; 1970 Feb; 18(2):131-40. PubMed ID: 4393800
[No Abstract] [Full Text] [Related]
25. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
Marmo E; Caputi AP; Saini RK
Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671
[No Abstract] [Full Text] [Related]
26. Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.
Dollery CT; Paterson JW; Conolly ME
Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4390767
[No Abstract] [Full Text] [Related]
27. On the psychopharmacology of beta adrenergic blockade.
Greenblatt DJ; Shader RI
Curr Ther Res Clin Exp; 1972 Sep; 14(9):615-25. PubMed ID: 4404445
[No Abstract] [Full Text] [Related]
28. [Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
Gorodinskaia VIa
Vrach Delo; 1971 Apr; 7():4-9. PubMed ID: 4400881
[No Abstract] [Full Text] [Related]
29. [Clinical value of beta-adrenergic receptor blocking agents].
Chmielewski T
Wiad Lek; 1970 Aug; 23(15):1317-20. PubMed ID: 4917574
[No Abstract] [Full Text] [Related]
30. [Beta-adrenergic receptor blocking agents].
Hayase S; Ito H
Nihon Rinsho; 1970 Mar; 28 Suppl():680-3. PubMed ID: 4393440
[No Abstract] [Full Text] [Related]
31. [Treatment with beta receptor blockers].
Lydtin H
Dtsch Med Wochenschr; 1969 Dec; 94(49):2560-2. PubMed ID: 4391114
[No Abstract] [Full Text] [Related]
32. [A beta receptor blocking agent in heart therapy].
Schmidt-Voigt J
Med Welt; 1966 Jan; 1():23-6. PubMed ID: 5942360
[No Abstract] [Full Text] [Related]
33. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
34. The treatment of functional heart disorders with beta-adrenergic blocking agents.
Imhof P; Brunner H
Postgrad Med J; 1970 Nov; ():Suppl:96-9. PubMed ID: 4395467
[No Abstract] [Full Text] [Related]
35. Propranolol--new uses.
Med Lett Drugs Ther; 1973 Jun; 15(12):49-51. PubMed ID: 4705036
[No Abstract] [Full Text] [Related]
36. [New special drugs registered in Austria. Praetolol].
Wien Klin Wochenschr; 1972 Jan; 84(4):69-71. PubMed ID: 5012931
[No Abstract] [Full Text] [Related]
37. The role of beta-blockers as a cornerstone of cardiovascular therapy.
Hollenberg NK
Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194
[TBL] [Abstract][Full Text] [Related]
38. Clinical uses of inhibition of beta-adrenergic receptors with propranolol.
Stampfer M; Epstein SE
Calif Med; 1969 Jan; 110(1):85-6. PubMed ID: 5762469
[No Abstract] [Full Text] [Related]
39. Propranolol--ten years from introduction.
Dollery CT; George C
Cardiovasc Clin; 1974; 6(2):255-68. PubMed ID: 4613461
[No Abstract] [Full Text] [Related]
40. Calcium antagonists for cardiovascular disease.
Drug Ther Bull; 1993 Oct; 31(21):81-4. PubMed ID: 8269825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
